Publication | Open Access
Lipoprotein(a) as a cardiovascular risk factor: current status
1.7K
Citations
37
References
2010
Year
We recommend screening for elevated Lp(a) in those at intermediate or high CVD/CHD risk, a desirable level <50 mg/dL as a function of global cardiovascular risk, and use of niacin for Lp(a) and CVD/CHD risk reduction.
| Year | Citations | |
|---|---|---|
Page 1
Page 1